Alfredo de la Rubia - Concepedia

Author

Alfredo de la Rubia

Universidad de Extremadura

Also Known As

A De la Rubia, A. de la Rubia, Alfredo de la Rubia, Alfredo de la Rubia

Publications

630

Citations

H-Index

Concepts

All Affiliations

Universidad de Extremadura Instituto de Arqueología-Mérida University of Beira Interior University of Debrecen

About

Alfredo de la Rubia is an author at Universidad de Extremadura specializing in medicine, psychiatry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	316
2	Pharmacology	5	5	230
3	Social Sciences	2	2	69
4	Public Health	1	1	41
5	Family Medicine	1	1	17

Alfredo de la Rubia

Publications

598

Citations

H-Index

Page 1

	Year	Citations
QTc Interval, CYP2D6 and CYP2C9 Genotypes and Risperidone Plasma Concentrations Adrián LLerena, Roland Berecz, Pedro Dorado, Journal of Psychopharmacology	2004	83
QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients Adrián LLerena, Roland Berecz, Alfredo de la Rubia, Journal of Psychopharmacology	2002	57
Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients Adrián LLerena, Pedro Dorado, Roland Berecz, Journal of Chromatography B PsychiatryPsychotropic MedicationPharmacologyPsychopharmacologyHuman Plasma	2002	56
Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype Roland Berecz, Alfredo de la Rubia, Pedro Dorado, European Journal of Clinical Pharmacology Molecular PharmacologyMedicineCyp2c9 GenotypePhysiologyNicotine	2003	52
Effect of Thioridazine Dosage on the Debrisoquine Hydroxylation Phenotype in Psychiatric Patients With Different CYP2D6 Genotypes Adrián LLerena, Roland Berecz, Alfredo de la Rubia, Therapeutic Drug Monitoring Cyp2d6 GenotypePsychopharmacologyNeuropsychiatryPharmacotherapySocial Sciences	2001	52
Low frequency of CYP2D6 poor metabolizers among schizophrenia patients Adrián LLerena, Pedro Dorado, Eva Peñas‐Lledó, The Pharmacogenomics Journal PsychiatryMedicinePsychopharmacologySchizophreniaSchizophrenia Patients	2007	46
Schizophrenia and tobacco smoking in a Spanish psychiatric hospital Adrián LLerena, Alfredo de la Rubia, Eva Peñas‐Lledó, Schizophrenia Research Tobacco ControlSubstance AbusePsychiatryPsychotic DisorderTobacco Use	2003	41
Relationship between Risperidone and 9-hydroxy-risperidone Plasma Concentrations and CYP2D6 Enzyme Activity in Psychiatric Patients Roland Berecz, Adrián LLerena, Alfredo de la Rubia, Pharmacopsychiatry	2002	39
Use of the Mesoridazine/Thioridazine Ratio as a Marker for CYP2D6 Enzyme Activity Adrián LLerena, Roland Berecz, Alfredo de la Rubia, Therapeutic Drug Monitoring	2000	39
CYP2C9 gene and susceptibility to major depressive disorder Adrián LLerena, Roland Berecz, Pedro Dorado, The Pharmacogenomics Journal Cyp2c9 GenePsychiatryGeneticsPsychiatric GeneticsDepression	2003	28

Page 1